Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neal Lakdawala

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Medrxiv : the Preprint Server for Health Sciences|September 26, 2025
Incidence and Outcomes of Atrial Fibrillation and Systolic Dysfunction in Patients Receiving Mavacamten for Obstructive Hypertrophic Cardiomyopathy: A Multicenter StudyOlives Nguyen, Jack Wiedrick, Daniele Massera, et al.
Journal of Cardiac Failure|March 3, 2026
Incidence and Outcomes of Atrial Fibrillation and Systolic Dysfunction in Patients Receiving Mavacamten for Obstructive Hypertrophic Cardiomyopathy: A Multicenter StudyOlives Nguyen, Jack Wiedrick, Daniele Massera, et al.
Research Square|February 6, 2026
Leveraging the shared and opposing genetic mechanisms in the heritable cardiomyopathiesDaria Kramarenko, Poeya Haydarlou, George Powell, et al.
Medrxiv : the Preprint Server for Health Sciences|July 16, 2025
Diagnostic Criteria and Disease Staging for Desmoplakin CardiomyopathyEric Smith, Alessio Gasperetti, Richard T Carrick, et al.
Circulation|August 20, 2025
Prognostic Role of Myocarditis-Like Episodes and Their Treatment in Patients With Pathogenic Desmoplakin VariantsAlessio Gasperetti, Steven A Muller, Giovanni Peretto, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Medrxiv : the Preprint Server for Health Sciences|September 26, 2025
Incidence and Outcomes of Atrial Fibrillation and Systolic Dysfunction in Patients Receiving Mavacamten for Obstructive Hypertrophic Cardiomyopathy: A Multicenter StudyOlives Nguyen, Jack Wiedrick, Daniele Massera, et al.
Journal of Cardiac Failure|March 3, 2026
Incidence and Outcomes of Atrial Fibrillation and Systolic Dysfunction in Patients Receiving Mavacamten for Obstructive Hypertrophic Cardiomyopathy: A Multicenter StudyOlives Nguyen, Jack Wiedrick, Daniele Massera, et al.
Research Square|February 6, 2026
Leveraging the shared and opposing genetic mechanisms in the heritable cardiomyopathiesDaria Kramarenko, Poeya Haydarlou, George Powell, et al.
Medrxiv : the Preprint Server for Health Sciences|July 16, 2025
Diagnostic Criteria and Disease Staging for Desmoplakin CardiomyopathyEric Smith, Alessio Gasperetti, Richard T Carrick, et al.
Circulation|August 20, 2025
Prognostic Role of Myocarditis-Like Episodes and Their Treatment in Patients With Pathogenic Desmoplakin VariantsAlessio Gasperetti, Steven A Muller, Giovanni Peretto, et al.
Pageof 2